Get the real deal on beauty treatments—real doctors, real reviews, and real photos with real results.Here's how we earn your trust.
The simple answer is probably but given the fact that you do have a pretty serious condition, I would strongly recommend checking with your opthalmologist before using Latisse. I hope that helps!
Yes, you can use Latisse even if you have macular degeneration. You should continue to be followed by your Ophthalmologist regularly for monitoring of any progression of macular degeneration. Any subtle changes in your vision need to be reported to your Ophthalmologist, however, there is minimal chance for any penetration of Latisse into the eye when applied correctly. There are a few published reports of eyedrops in the same class as Latisse, causing some swelling of the retina in post-operative cases or rarely in wet macular degeneration, so you should consult with your Ophthalmologist throughout treatment.
In general, Latisse applied properly to eyelashes does not penetrate the ocular surface in as high concentrations as Lumigan, which is the glaucoma eyedrop which is chemically identical to Latisse. Many macular degeneration patients have used Lumigan eyedrops without any contraindication from the FDA or manufacturer. That said, ask your ophthalmologist next visit.
Consult your ophthalmologist about this - Latisse is a prostaglandin analog. This class of of medication has been associated with cystoid macular edema which is distinct from macular degeneration. There was a paper published in 2006 that looked at prostaglandin analogs used for glaucoma and its association with the development of choroidal neovascular membrances (wet AMD) in patients with both glaucoma and AMD and they found no association. However, I would discuss this with your eye doctor to determine what the best thing for your eyes are.
You have a serious diagnosis of macular degeneration. Do not complicate things and do not use any thing without asking your ophthalmologist.
The use of Latisse in patients who have macular degeneration or cataracts is not contraindicated. Latisse is a product that is used to lengthen, thicken and elongate the eyelashes. It is applied along the upper eyelid margin once nightly for the first 12 weeks, then every other or every third night, thereafter, to maintain the effect. Latisse should be stopped about 3 days before cataract surgery or Lasik surgery, but can be started again about one week after surgery.
The eye is exposed to a very small amount of Latisse even when it is properly applied as directed to the upper eyelid margin using the supplied applicator. This has been demonstrated by applying a colored dye to the eyelid margin and watching its migration. At present, use of Latisse is considered safe if you have macular degeneration but should only be used under the guidance of your ophthalmologist.
Latisse is safe to use after surgery and should not affect the wound unless you put excess pressure on the wound. If you use it gently, you shouldn't have a problem but it should be discussed with your operating surgeon before you begin using it again...
We have heard from an Allergan representative that there are studies being done for the use of Latisse or Latisse-like product for hair loss on the scalp. Although off-label, many female patients have been using the product on the eyebrow area with reported success. Unfortunately,...
Latisse keeps the eyelashes in their growth phase. After 8 weeks use, clients can generally see their lashes becoming longer, thicker and darker. These results will be maintained with the continued use of Latisse. Once you cease use of the product, the lashes will return to their original state.
The pivotal Latisse trial used to approve the use of Bitamoprost topically for hypotrichosis utilized one applicator per eye. The FDA approved the use of this medication with this technique to evenly distribute the medication and prevent local infections through repetitive use. I usually tell my...
The studies offered by allergan give you the best insight for your expectations. 78 % of patients respond to latisse by the fourth month, which means you have to stay with the product early even if you don't always see things right away (around 50% respond at 2 months). The...
What’s trending? Who’s turning heads? Which TikTok myths need busting? We’ve got you. No fluff, no gatekeeping—just real talk. Get our free, unfiltered newsletter.